Adamas Pharmaceuticals, Inc.

The future prospects for IRLAB Therapeutics AB 's mesdopetam, and the firm's partnership with Ipsen SA , are looking shakier after the investigational Parkinson's disease drug missed its primary goa

Supernus Pharmaceuticals, Inc. announced that it will acquire Adamas Pharmaceuticals, Inc. and its slow-growing Parkinson’s disease drug Gocovri on 11 October in a deal that will broaden Supernus’s

February started emphatically at the US FDA, with novel approvals from both the drugs and biologics centers, including the first biologic with a Regenerative Medicine Advanced Therapy (RMAT) designati

"COVID-19 is a great reminder and a testament that biopharma's core mission is to meet patient and society's needs." These words of Lihua Yu , president and chief data science officer of Eisai Co.,